Jian-Min Yang

426 total citations
21 papers, 353 citations indexed

About

Jian-Min Yang is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Jian-Min Yang has authored 21 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Cell Biology and 6 papers in Oncology. Recurrent topics in Jian-Min Yang's work include Glycosylation and Glycoproteins Research (7 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Immunotherapy and Immune Responses (3 papers). Jian-Min Yang is often cited by papers focused on Glycosylation and Glycoproteins Research (7 papers), Proteoglycans and glycosaminoglycans research (6 papers) and Immunotherapy and Immune Responses (3 papers). Jian-Min Yang collaborates with scholars based in China, United States and Thailand. Jian-Min Yang's co-authors include James J. Mulé, Koïchi Shimizu, Eric A. Shelden, David A. Fox, Raj Gupta, Judith Endres, Yoshitaka Morita, Kevin T. McDonagh, Hui‐Ju Wang and Zai‐yuan Ye and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Nuclear Physics A.

In The Last Decade

Jian-Min Yang

21 papers receiving 345 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian-Min Yang China 9 155 130 80 48 40 21 353
Silvia Danielian Argentina 11 309 2.0× 159 1.2× 79 1.0× 29 0.6× 62 1.6× 24 498
J Woodliff United States 6 121 0.8× 172 1.3× 152 1.9× 91 1.9× 41 1.0× 10 440
A Miyajima Japan 7 247 1.6× 174 1.3× 101 1.3× 24 0.5× 35 0.9× 7 456
Jayant Bhalerao United States 9 188 1.2× 126 1.0× 52 0.7× 18 0.4× 13 0.3× 10 378
Jens Grosse Germany 11 255 1.6× 139 1.1× 218 2.7× 56 1.2× 17 0.4× 19 443
Hoa Nguyen United States 9 74 0.5× 229 1.8× 124 1.6× 20 0.4× 77 1.9× 23 490
Elena Chklovskaia Switzerland 8 247 1.6× 207 1.6× 76 0.9× 39 0.8× 18 0.5× 12 497
S.F. Tsai Taiwan 14 178 1.1× 195 1.5× 131 1.6× 59 1.2× 32 0.8× 20 565
Hey Chong United States 13 442 2.9× 108 0.8× 98 1.2× 16 0.3× 31 0.8× 35 649
K. Acland United Kingdom 13 87 0.6× 165 1.3× 367 4.6× 32 0.7× 61 1.5× 24 530

Countries citing papers authored by Jian-Min Yang

Since Specialization
Citations

This map shows the geographic impact of Jian-Min Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian-Min Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian-Min Yang more than expected).

Fields of papers citing papers by Jian-Min Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian-Min Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian-Min Yang. The network helps show where Jian-Min Yang may publish in the future.

Co-authorship network of co-authors of Jian-Min Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jian-Min Yang. A scholar is included among the top collaborators of Jian-Min Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian-Min Yang. Jian-Min Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Fei, Cheng Cheng, Wenhai Sui, et al.. (2024). Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis. Signal Transduction and Targeted Therapy. 9(1). 273–273. 16 indexed citations
2.
Li, Jinqi, Haihui Gu, Jian-Min Yang, & Baohua Qian. (2016). [Research progress of the side effect and application prospects of CAR-T cells in the treatment of malignant tumors].. PubMed. 37(2). 169–73. 1 indexed citations
3.
Huang, Wei, Lei Wang, Jing Du, & Jian-Min Yang. (2015). [The value of narrow-band imaging with magnifying endoscopy in diagnosis of early gastric cancer: a meta-analysis].. PubMed. 44(4). 435–42. 2 indexed citations
4.
Zhang, Jun, Jian-Min Yang, Yuan Cai, et al.. (2014). Multiple antigenic polypeptide composed of heparanase B-cell epitopes shrinks human hepatocellular carcinoma in mice. Oncology Reports. 33(3). 1248–1256. 8 indexed citations
5.
Wang, Lei, Wei Huang, Jing Du, Youwei Chen, & Jian-Min Yang. (2014). Diagnostic Yield of the Light Blue Crest Sign in Gastric Intestinal Metaplasia: A Meta-Analysis. PLoS ONE. 9(3). e92874–e92874. 23 indexed citations
6.
Zhang, Jun, Jian-Min Yang, Daiming Fan, et al.. (2013). Peptide FLNPDVLDI of heparanase is a novel HLA-A2-restricted CTL epitope and elicits potent immunological antitumor effects in vitro with an 8-branched design. Oncology Reports. 29(5). 1955–1961. 6 indexed citations
7.
Zhang, Jun, Jian-Min Yang, Hui‐Ju Wang, Guoqing Ru, & Daiming Fan. (2013). Synthesized Multiple Antigenic Polypeptide Vaccine Based on B-Cell Epitopes of Human Heparanase Could Elicit a Potent Antimetastatic Effect on Human Hepatocellular Carcinoma In Vivo. PLoS ONE. 8(1). e52940–e52940. 15 indexed citations
8.
9.
Yang, Jian-Min, et al.. (2010). Advances in research on circulating tumor cells. World Chinese Journal of Digestology. 18(11). 1081–1081. 1 indexed citations
10.
Wang, Hui‐Ju, Jian-Min Yang, Yonglie Zhou, et al.. (2009). [Effects of anti-heparanase antibody on the growth and invasion of HCCLM6 human hepatocellular carcinoma cells].. PubMed. 31(1). 10–4. 4 indexed citations
11.
Yang, Jian-Min, Hui‐Ju Wang, Zai‐yuan Ye, et al.. (2009). Screening and identification of novel B cell epitopes in human heparanase and their anti-invasion property for hepatocellular carcinoma. Cancer Immunology Immunotherapy. 58(9). 1387–1396. 21 indexed citations
12.
He, Yi, Jian-Min Yang, Jianmin Wang, et al.. (2008). [Synergistic effects of arsenic trioxide and proteasome inhibitor bortezomib on apoptosis induction in Raji cell line].. PubMed. 16(4). 794–8. 5 indexed citations
13.
Yang, Jian-Min, et al.. (2007). KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97‐H cells in vitro and in animal models. Liver International. 28(1). 132–139. 33 indexed citations
14.
Chen, Yongwei, et al.. (2006). Single nucleotide polymorphism of interferon-gamma gene +874 T/A in colorectal cancer. World Chinese Journal of Digestology. 14(20). 2022–2022. 2 indexed citations
15.
Peng, Zhihong, et al.. (2004). Effects of metastasis-suppressor gene KAI1 on viscoelastic properties of hepatocellular carcinoma MHCC97-H cells with high metastatic potential. World Chinese Journal of Digestology. 12(5). 1040–1040. 1 indexed citations
16.
Yang, Jian-Min, et al.. (2003). Effects of insulin‐like growth factors‐IR and ‐IIR antisense gene transfection on the biological behaviors of SMMC‐7721 human hepatoma cells. Journal of Gastroenterology and Hepatology. 18(3). 296–301. 11 indexed citations
17.
Morita, Yoshitaka, Jian-Min Yang, Raj Gupta, et al.. (2001). Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis. Journal of Clinical Investigation. 107(10). 1275–1284. 165 indexed citations
18.
Yang, Jian-Min. (1999). Effect of HCV infection on expression of several cancer-associated gene products in HCC. World Journal of Gastroenterology. 5(1). 25–25. 18 indexed citations
19.
Warner, R. E., D.L. Friesel, P. Schwändt, et al.. (1986). The noncoplanar 7Li(p, pd)5He and 7Li(p, pt)4He reactions at Ep = 200 MeV, and evidence for deuteron clustering in 7Li. Nuclear Physics A. 453(4). 605–619. 6 indexed citations
20.
Miller, D.W., J.D. Brown, D.L. Friesel, et al.. (1986). Energy dependence of(p→24,d) cross section and analyzing-power measurements from 50 to 150 MeV. Physical Review C. 33(1). 22–30. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvia Danielian Breakdown of academic impact, for papers by J Woodliff Breakdown of academic impact, for papers by A Miyajima Breakdown of academic impact, for papers by Jayant Bhalerao Breakdown of academic impact, for papers by Jens Grosse Breakdown of academic impact, for papers by Hoa Nguyen Breakdown of academic impact, for papers by Elena Chklovskaia Breakdown of academic impact, for papers by S.F. Tsai Breakdown of academic impact, for papers by Hey Chong Breakdown of academic impact, for papers by K. Acland
Rankless by CCL
2026